Statin-induced myopathy: a review and update

Author： Abd Thura T   Jacobson Terry A  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.3, 2011-05, pp. : 373-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SLCO1B1 variants and increased risk of statin-induced myopathy

By  

Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Statin-induced myopathy: minimize the risk and manage according to symptoms and creatine kinase levels

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 10, 2010-10 ,pp. : 21-23

Adis International

Access to resources Recommend Favorite

Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy: Implications for Risk Assessment, Prevention and Treatment

By Chatzizisis Yiannis S.   Koskinas Konstantinos C.  

Drug Safety, Vol. 33, Iss. 3, 2010-03 ,pp. : 171-187

Adis International

Access to resources Recommend Favorite

Statin-induced liver disease a "myth"

By  

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy

By >  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 347-350

Adis International

Access to resources Recommend Favorite